|
End-of-day quote
Dhaka S.E.
01/10/2026
|
5-day change | 1st Jan Change | ||
| 257.70 BDT | -2.46% |
|
-1.98% | -24.58% |
| Market Cap | 6.37B 51.88M 46.1M 43.02M 39.21M 73.96M 4.99B 74.65M 521M 202M 2.55B 195M 191M 8.18B | P/E 2024 |
231x | P/E 2025 | 182x |
|---|---|---|---|---|---|
| Enterprise Value | 6.67B 54.34M 48.28M 45.06M 41.07M 77.46M 5.22B 78.19M 545M 211M 2.67B 204M 200M 8.57B | EV / Sales 2024 |
12.2x | EV / Sales 2025 | 10.1x |
| Free-Float |
59.39% | Yield 2024 |
0.25% | Yield 2025 | 0.64% |
| 1 day | -2.46% | ||
| 1 week | -1.98% | ||
| Current month | -2.46% | ||
| 1 month | +14.74% | ||
| 3 months | -16.41% | ||
| 6 months | -23.98% | ||
| Current year | -24.58% |
| 1 week | 256.9 |  | 292 |
| 1 month | 159 | | 295 |
| Current year | 159 | | 391.8 |
| 1 year | 159 | | 530 |
| 3 years | 159 | | 726.9 |
| 5 years | 75 | | 1,000 |
| 10 years | 44 | | 1,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 31/12/2013 | |
| Director of Finance/CFO | - | 07/11/2020 | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 31/12/2013 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 04/05/1983 |
| Director/Board Member | 45 | 31/12/1999 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.46% | -1.98% | -51.27% | -19.34% | 42.72M | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.46% | -3.84% | +19.33% | +49.50% | 369.72B | |
| Weighted average by Cap. | +0.42% | -3.33% | +30.52% | +68.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827M 6.74M 5.99M 5.59M 5.09M 9.6M 648M 9.69M 67.6M 26.2M 331M 25.29M 24.74M 1.06B | 665M 5.41M 4.81M 4.49M 4.09M 7.72M 520M 7.79M 54.33M 21.05M 266M 20.32M 19.88M 854M |
| Net income | 42.33M 345K 306K 286K 261K 491K 33.13M 496K 3.46M 1.34M 16.94M 1.29M 1.27M 54.36M | 35.02M 285K 253K 236K 216K 406K 27.41M 410K 2.86M 1.11M 14.01M 1.07M 1.05M 44.97M |
| Net Debt | 290M 2.36M 2.1M 1.96M 1.79M 3.37M 227M 3.4M 23.73M 9.2M 116M 8.88M 8.69M 373M | 302M 2.46M 2.19M 2.04M 1.86M 3.51M 236M 3.54M 24.68M 9.57M 121M 9.23M 9.03M 388M |
Employees
563
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | BDT 257.70 | -2.46% | 301,125 |
| 30/09/26 | BDT 264.20 | -1.67% | 258,268 |
| 29/09/26 | BDT 268.70 | -4.58% | 545,942 |
| 28/09/26 | BDT 281.60 | +0.68% | 529,467 |
| 27/09/26 | BDT 279.70 | +6.39% | 754,374 |
- Stock Market
- Stocks
- ORIONINFU Stock
Select your edition
All financial news and data tailored to specific country editions
